May 7, 2024 7:45am EDT Sigyn Therapeutics™ Discloses Publication of “Sigyn TherapyTM, an Emerging Candidate to Address Endotoxemia, Sepsis, and Drug-Resistant Viral & Bacterial Infections.”
